<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Raloxifene</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Raloxifene">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Raloxifene</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Raloxifene</b>, sold under the brand name <b>Evista</b> among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids.<span class="mw-ref" id="cite_ref-AHFS2019_4-0"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> For osteoporosis it is less preferred than bisphosphonates.<span class="mw-ref" id="cite_ref-AHFS2019_4-1"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is also used to reduce the risk of breast cancer in those at high risk.<span class="mw-ref" id="cite_ref-AHFS2019_4-2"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_4-3"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Raloxifene</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Raloxifene_Chemical_Structure_V.1.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Raloxifene_Chemical_Structure_V.1.svg.png" data-file-width="768" data-file-height="391" data-file-type="drawing" height="127" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Raloxifene_molecule_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Raloxifene_molecule_ball.png" data-file-width="2412" data-file-height="1584" data-file-type="bitmap" height="164" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Evista, Optruma, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Keoxifene; Pharoxifene; LY-139481; LY-156758; CCRIS-7129</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/raloxifene-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/raloxifene-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/raloxifene-hydrochloride.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a698007.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a698007.html'" tppabs="https://medlineplus.gov/druginfo/meds/a698007.html" class="external text external">a698007</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Raloxifene  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Raloxifene'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Raloxifene" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Raloxifene  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Raloxifene'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Raloxifene" class="external text external">Raloxifene</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Evista&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Evista&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Evista&SearchType=BasicSearch" class="external text external">Evista</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>X (High risk)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Selective estrogen receptor modulator</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G03XC01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03XC01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03XC01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03XC01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>2%<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-0"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-0"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;95%<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-1"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-1"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver, intestines (glucuro-<br>nidation);<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-2"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-2"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Jeong_3-0"><a href="#cite_note-Jeong-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> CYP450 system not involved<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-3"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-3"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>Single-dose: 28 hours<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-4"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-4"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><br>Multi-dose: 33 hours<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-5"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces<span class="mw-ref" id="cite_ref-pmid10428318_2-5"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">[6-hydroxy-2-(4-hydroxyphenyl)-benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]-methanone</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=84449-90-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=84449-90-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=84449-90-1" class="external text external">84449-90-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup> <br>82640-04-8 (hydrochloride)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5035'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5035" class="external text external">5035</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820" class="external text external">2820</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00481'" tppabs="https://www.drugbank.ca/drugs/DB00481" class="external text external">DB00481</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4859.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4859.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4859.html" class="external text external">4859</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YX9162EO3I  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YX9162EO3I'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YX9162EO3I" class="external text external">YX9162EO3I</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8772'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8772" class="external text external">CHEBI:8772</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL81  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL81'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL81" class="external text external">ChEMBL81</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>RAL (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RAL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RAL'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RAL" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RAL&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RAL&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RAL&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3023550  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3023550'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3023550" class="external text external">DTXSID3023550</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.212.655  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.212.655'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.212.655" class="external text external">100.212.655</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>28</sub><span>H</span><sub>27</sub><span>N</span><span>O</span><sub>4</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>473.584<span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1c3ccc%28O%29cc3sc1c2ccc%28O%29cc2%29c5ccc%28OCCN4CCCCC4%29cc5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1c3ccc%28O%29cc3sc1c2ccc%28O%29cc2%29c5ccc%28OCCN4CCCCC4%29cc5'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1c3ccc%28O%29cc3sc1c2ccc%28O%29cc2%29c5ccc%28OCCN4CCCCC4%29cc5" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(c1c3ccc(O)cc3sc1c2ccc(O)cc2)c5ccc(OCCN4CCCCC4)cc5</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:GZUITABIAKMVPG-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464379874&page2=Raloxifene  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464379874&page2=Raloxifene'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464379874&page2=Raloxifene" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include hot flashes, leg cramps, swelling, and joint pain.<span class="mw-ref" id="cite_ref-AHFS2019_4-4"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Severe side effects may include blood clots and stroke.<span class="mw-ref" id="cite_ref-AHFS2019_4-5"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Use during pregnancy may harm the baby.<span class="mw-ref" id="cite_ref-AHFS2019_4-6"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The medication may worsen menstrual symptoms.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Raloxifene is a selective estrogen receptor modulator (SERM) and therefore a mixed agonist–antagonist of the estrogen receptor (ER).<span class="mw-ref" id="cite_ref-AHFS2019_4-7"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It has estrogenic effects in bone and antiestrogenic effects in the breasts and uterus.<span class="mw-ref" id="cite_ref-AHFS2019_4-8"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<p>Raloxifene was approved for medical use in the United States in 1997.<span class="mw-ref" id="cite_ref-AHFS2019_4-9"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2019_4-10"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-BNF76_6-0"><a href="#cite_note-BNF76-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> A month supply in the United Kingdom costs the NHS about 3.50 £ as of 2019.<span class="mw-ref" id="cite_ref-BNF76_6-1"><a href="#cite_note-BNF76-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In the United States the wholesale cost of this amount is about $16.<span class="mw-ref" id="cite_ref-NADAC2019_7-0"><a href="#cite_note-NADAC2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In 2017, it was the 330th most commonly prescribed medication in the United States, with more than 900 thousand prescriptions.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Raloxifene is used for the treatment and prevention of osteoporosis in postmenopausal women.<span class="mw-ref" id="cite_ref-:0_9-0"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It is used at a dosage of 60<span>&nbsp;</span>mg/day for both the prevention and treatment of osteoporosis.<span class="mw-ref" id="cite_ref-Mosby2013_10-0"><a href="#cite_note-Mosby2013-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In the case of either osteoporosis prevention or treatment, supplemental <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a> and <a href="Vitamin_D.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_D" title="Vitamin D">vitamin D</a> should be added to the diet if daily intake is inadequate.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Raloxifene is used to reduce the risk of breast cancer in postmenopausal women. It is used at a dosage of 60<span>&nbsp;</span>mg/day for this indication.<span class="mw-ref" id="cite_ref-Mosby2013_10-1"><a href="#cite_note-Mosby2013-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In the Multiple Outcomes of Raloxifene (MORE) clinical trial, raloxifene decreased the risk of all types of breast cancer by 62%, of invasive breast cancer by 72%, and of invasive estrogen receptor-positive breast cancer by 84%.<span class="mw-ref" id="cite_ref-pmid15755972_12-0"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Conversely, it does not reduce the risk of estrogen receptor-negative breast cancer.<span class="mw-ref" id="cite_ref-pmid15755972_12-1"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> There were no obvious differences in effectiveness of raloxifene in the MORE trial for prevention of breast cancer at a dosage of 60<span>&nbsp;</span>mg/m<sup>2</sup>/day relative to 120<span>&nbsp;</span>mg/m<sup>2</sup>/day.<span class="mw-ref" id="cite_ref-pmid15755972_12-2"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In the Study of Tamoxifen and Raloxifene (STAR) trial, 60<span>&nbsp;</span>mg/day raloxifene was 78% as effective as 20<span>&nbsp;</span>mg/day <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a> in preventing non-invasive breast cancer.<span class="mw-ref" id="cite_ref-BlandCopeland2017_13-0"><a href="#cite_note-BlandCopeland2017-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Women with undetectable levels of estradiol (&lt;2.7<span>&nbsp;</span>pg/mL) have a naturally low risk of breast cancer and, in contrast to women with detectable levels of estradiol, do not experience significant benefit from raloxifene in terms of reduction of breast cancer risk.<span class="mw-ref" id="cite_ref-pmid15755972_12-3"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Raloxifene is contraindicated in lactating women or women who are or who may become pregnant.<span class="mw-ref" id="cite_ref-Label_14-0"><a href="#cite_note-Label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It also may be of concern to women with active or past history of venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis.<span class="mw-ref" id="cite_ref-pmid23942473_15-0"><a href="#cite_note-pmid23942473-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Common side effects of raloxifene include hot flashes (25–28% vs. 18–21% for placebo),<span class="mw-ref" id="cite_ref-pmid15755972_12-4"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> vaginal dryness, and leg cramps (generally mild; 5.5% vs. 1.9% for placebo).<span class="mw-ref" id="cite_ref-Label_14-1"><a href="#cite_note-Label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-MorelloWurz2003_1-6"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Goldstein2000_16-0"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Raloxifene does not cause breast tenderness, endometrial hyperplasia, menstrual bleeding, or endometrial cancer.<span class="mw-ref" id="cite_ref-pmid11281162_17-0"><a href="#cite_note-pmid11281162-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> It does not appear to affect cognition or memory.<span class="mw-ref" id="cite_ref-pmid23942473_15-1"><a href="#cite_note-pmid23942473-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-pmid15755972_12-5"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Raloxifene is a teratogen; i.e., it can cause developmental abnormalities such as birth defects.</p>

<p>Raloxifene may infrequently cause serious blood clots to form in the legs, lungs, or eyes.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-7"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Other reactions experienced include leg swelling/pain, trouble breathing, chest pain, and vision changes. Black box warnings were added to the label of raloxifene in 2007 warning of increased risk of death due to stroke for postmenopausal women with documented coronary heart disease or at increased risk for major coronary events, as well as increased risk for deep vein thrombosis and pulmonary embolism.<span class="mw-ref" id="cite_ref-Label_14-2"><a href="#cite_note-Label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> The risk of venous thromboembolism with raloxifene is increased by several-fold in postmenopausal women (<abbr>RR</abbr> = 3.1).<span class="mw-ref" id="cite_ref-Park2002_18-0"><a href="#cite_note-Park2002-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-pmid15755972_12-6"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Raloxifene has a lower risk of thromboembolism than tamoxifen.<span class="mw-ref" id="cite_ref-BlandCopeland2017_13-1"><a href="#cite_note-BlandCopeland2017-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> In the MORE trial, raloxifene caused a 40% decrease in risk of cardiovascular events in women who were at increased risk for coronary artery disease, although there was no decrease in cardiovascular events for the group as a whole.<span class="mw-ref" id="cite_ref-pmid15755972_12-7"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>A report in September 2009 from Health and Human Services' Agency for Healthcare Research and Quality suggests that tamoxifen and raloxifene, used to treat breast cancer, significantly reduce invasive breast cancer in midlife and older women, but also increase the risk of adverse side effects.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>A recent human case report in July 2016 suggests that raloxifene may in fact, at some point, also stimulate breast cancer growth leading to a reduction of advanced breast cancer disease upon the withdrawal of the drug.<span class="mw-ref" id="cite_ref-Lemmo2016_20-0"><a href="#cite_note-Lemmo2016-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>Unlike other SERMs, such as <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, raloxifene has no risk of uterine hyperplasia or endometrial cancer (<abbr>RR</abbr> = 0.8).<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-8"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Park2002_18-1"><a href="#cite_note-Park2002-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-BlandCopeland2017_13-2"><a href="#cite_note-BlandCopeland2017-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Raloxifene does not increase the incidence of breast pain or tenderness in postmenopausal women.<span class="mw-ref" id="cite_ref-Goldstein2000_16-1"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Haskell2003_21-0"><a href="#cite_note-Haskell2003-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Raloxifene has been studied in clinical trials across a dosage range of 30 to 600<span>&nbsp;</span>mg/day, and was well-tolerated at all dosages.<span class="mw-ref" id="cite_ref-Goldstein2000_16-2"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Mechanism_of_action">Mechanism of action</h4></summary>
    
<p>Raloxifene is a selective estrogen receptor modulator (SERM) and hence is a mixed agonist and antagonist of the estrogen receptor (ER) in different tissues.<span class="mw-ref" id="cite_ref-AHFS2019_4-11"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It has estrogenic activity in some tissues, such as bone and the liver, and antiestrogenic activity in other tissues, such as the breasts and uterus.<span class="mw-ref" id="cite_ref-AHFS2019_4-12"><a href="#cite_note-AHFS2019-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Its affinity (K<sub>d</sub>) for the ERα is approximately 50<span>&nbsp;</span>pM, which is similar to that of estradiol.<span class="mw-ref" id="cite_ref-Goldstein2000_16-3"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Relative to estradiol, raloxifene has been reported to possess about 8 to 34% of the affinity for the ERα and 0.5 to 76% of the affinity for the ERβ.<span class="mw-ref" id="cite_ref-WeathermanClegg2001_22-0"><a href="#cite_note-WeathermanClegg2001-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-pmid16554039_23-0"><a href="#cite_note-pmid16554039-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Raloxifene acts as a partial agonist of the ERα and as a pure antagonist of the ERβ.<span class="mw-ref" id="cite_ref-GreeneShiau2004_24-0"><a href="#cite_note-GreeneShiau2004-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-BarkhemCarlsson1998_25-0"><a href="#cite_note-BarkhemCarlsson1998-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> In contrast to the classical ERs, raloxifene is an agonist of the G protein-coupled estrogen receptor (GPER) (<abbr>EC<sub>50</sub></abbr> = 10–100<span>&nbsp;</span>nM), a membrane estrogen receptor.<span class="mw-ref" id="cite_ref-pmid26023144_26-0"><a href="#cite_note-pmid26023144-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-pmid24379833_27-0"><a href="#cite_note-pmid24379833-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Clinical_effects">Clinical effects</h4></summary>
    
<p>Raloxifene has antiestrogenic effects in the mammary glands in preclinical studies.<span class="mw-ref" id="cite_ref-Goldstein2000_16-4"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> In accordance, raloxifene reduces breast density in postmenopausal women, a known risk factor for breast cancer.<span class="mw-ref" id="cite_ref-pmid20832226_28-0"><a href="#cite_note-pmid20832226-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> It does not stimulate the uterus in postmenopausal women, and results in no increase in risk of endometrial thickening, vaginal bleeding, endometrial hyperplasia, or endometrial cancer.<span class="mw-ref" id="cite_ref-DraperChin2003_29-0"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Goldstein2000_16-5"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Haskell2003_21-1"><a href="#cite_note-Haskell2003-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> At the same time, raloxifene has minimal antiestrogenic effect in the uterus in premenopausal women.<span class="mw-ref" id="cite_ref-DraperChin2003_29-1"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> This may possibly be due to inadequate tissue exposure of the uterus to raloxifene in these estrogen-rich individuals.<span class="mw-ref" id="cite_ref-DraperChin2003_29-2"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>In premenopausal women, raloxifene increases levels of follicle-stimulating hormone (FSH) and <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>.<span class="mw-ref" id="cite_ref-pmid15755972_12-8"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Conversely, in postmenopausal women, raloxifene has been found to reduce levels of the gonadotropins, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a> (LH) and FSH, while not affecting levels of estradiol.<span class="mw-ref" id="cite_ref-pmid15755972_12-9"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-DraperChin2003_29-3"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Raloxifene also decreases prolactin levels in postmenopausal women.<span class="mw-ref" id="cite_ref-DraperChin2003_29-4"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> In men, raloxifene has been found to disinhibit the hypothalamic–pituitary–gonadal axis (HPG axis) and thereby increase total <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> levels.<span class="mw-ref" id="cite_ref-pmid25523084_30-0"><a href="#cite_note-pmid25523084-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-pmid27704479_31-0"><a href="#cite_note-pmid27704479-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid22319035_32-0"><a href="#cite_note-pmid22319035-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid15312253_33-0"><a href="#cite_note-pmid15312253-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> Due to the simultaneous increase in sex hormone-binding globulin (SHBG) levels however, free testosterone levels often remain unchanged in men during therapy with raloxifene.<span class="mw-ref" id="cite_ref-pmid25523084_30-1"><a href="#cite_note-pmid25523084-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>

<p>Raloxifene has <a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">estrogenic</a> effects on liver protein synthesis.<span class="mw-ref" id="cite_ref-pmid15755972_12-10"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It increases SHBG levels in both pre- and postmenopausal women as well as in men.<span class="mw-ref" id="cite_ref-pmid15755972_12-11"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-pmid25523084_30-2"><a href="#cite_note-pmid25523084-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> The medication decreases levels of total and low-density lipoprotein (LDL) <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a>, C-reactive protein, apolipoprotein B, and <a href="Homocysteine.htm" tppabs="https://ptable.com/wiki/compounds/A/Homocysteine" title="Homocysteine">homocysteine</a>.<span class="mw-ref" id="cite_ref-pmid15755972_12-12"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-DraperChin2003_29-5"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Conversely, it has little effect on levels of triglycerides and high-density lipoprotein (HDL).<span class="mw-ref" id="cite_ref-pmid15755972_12-13"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Raloxifene has been shown to inhibit the oxidation of LDL cholesterol <i>in vitro</i>.<span class="mw-ref" id="cite_ref-Goldstein2000_16-6"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The medication has been found to decrease insulin-like growth factor 1 (IGF-1) levels in pre- and postmenopausal women as well as in men.<span class="mw-ref" id="cite_ref-pmid27704479_31-1"><a href="#cite_note-pmid27704479-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> It has also been found to increase insulin-like growth factor binding protein 3 (IGFBP-3) levels in pre- and postmenopausal women.<span class="mw-ref" id="cite_ref-pmid15755972_12-14"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Due to activation of estrogen receptors in the liver, raloxifene has procoagulatory effects, such as decreasing levels of fibrinogen and influencing levels of other coagulation factors.<span class="mw-ref" id="cite_ref-pmid15755972_12-15"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-DraperChin2003_29-6"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Goldstein2000_16-7"><a href="#cite_note-Goldstein2000-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> For these reasons, raloxifene increases the risk of thrombosis.<span class="mw-ref" id="cite_ref-pmid15755972_12-16"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-DraperChin2003_29-7"><a href="#cite_note-DraperChin2003-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>Raloxifene increases bone mineral density in postmenopausal women but decreases it in premenopausal women.<span class="mw-ref" id="cite_ref-pmid15755972_12-17"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In the MORE trial, the risk of vertebral fractures was decreased by 30%, and bone mineral density was increased in the spine (by 2.1% at 60<span>&nbsp;</span>mg, 2.4% at 120<span>&nbsp;</span>mg) and femoral neck (2.6% at 60<span>&nbsp;</span>mg, 2.7% at 120<span>&nbsp;</span>mg).<span class="mw-ref" id="cite_ref-Park2002_18-2"><a href="#cite_note-Park2002-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It has been found to possess estrogenic effects in adipose tissue in postmenopausal women, promoting a shift from an android fat distribution to a gynoid fat distribution.<span class="mw-ref" id="cite_ref-XuLovre2016_34-0"><a href="#cite_note-XuLovre2016-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-FrancucciPantaleo2014_35-0"><a href="#cite_note-FrancucciPantaleo2014-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The medication has been found to increase levels of leptin, an adipokine.<span class="mw-ref" id="cite_ref-pmid15755972_12-18"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<span>
</span><table class="wikitable  mw-collapsible mw-collapsed" style="margin-left: auto; margin-right: auto; border: none;">
<caption class="nowrap"> Tissue-specific estrogenic and antiestrogenic activity of <abbr>SERMs</abbr></caption>
<tbody><tr>
<th rowspan="2">Medication</th><th rowspan="2">Breast</th><th rowspan="2">Bone</th><th colspan="4">Liver</th><th rowspan="2">Uterus</th><th rowspan="2">Vagina</th><th colspan="3">Brain</th></tr>
<tr>
<th>Lipids</th><th>Coagulation</th><th><abbr>SHBG</abbr></th><th><abbr>IGF-1</abbr></th><th>Hot flashes</th><th>Gonadotropins</th></tr>
<tr>
<td>Estradiol</td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td></tr>
<tr>
<td>"Ideal SERM"</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td>Bazedoxifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td>?</td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td>?</td></tr>
<tr>
<td><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td>?</td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Red">–</span></td><td>?</td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td>Lasofoxifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td>?</td><td>?</td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td>?</td></tr>
<tr>
<td>Ospemifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td>Raloxifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Red">–</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Red">–</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr class="sortbottom">
<td colspan="15" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Effect:</b> <span style="color:Blue">+</span> = Estrogenic / agonistic. <span style="color:Limegreen">±</span> = Mixed or neutral. <span style="color:Red">–</span> = Antiestrogenic / antagonistic. <b>Note:</b> SERMs generally increase gonadotropin levels in hypogonadal and eugonadal men as well as premenopausal women (antiestrogenic) but decrease gonadotropin levels in postmenopausal women (estrogenic). <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Absorption">Absorption</h4></summary>
    
<p>The absorption of raloxifene is approximately 60%.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-9"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-6"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> However, due to extensive first-pass metabolism, the absolute bioavailability of raloxifene is only 2.0%.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-10"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-7"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Raloxifene is rapidly absorbed from the intestines upon oral administration.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-11"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Peak plasma levels of raloxifene occur 0.5 to 6<span>&nbsp;</span>hours after an oral dose.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-12"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-8"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Distribution">Distribution</h4></summary>
    
<p>Raloxifene is widely distributed throughout the body.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-13"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> There is extensive distribution of raloxifene into the liver, serum, lungs, and kidneys.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-14"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The volume of distribution of raloxifene with a single 30 to 150<span>&nbsp;</span>mg oral dose is approximately 2348<span>&nbsp;</span>L.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-15"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid11006795_36-0"><a href="#cite_note-pmid11006795-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> Both raloxifene and its metabolites show high plasma protein binding (&gt;95%), including to both <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a> and α<sub>1</sub> acid glycoprotein, but not to sex hormone-binding globulin.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-16"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-9"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Metabolism">Metabolism</h4></summary>
    
<p>Raloxifene is metabolized in the liver and undergoes enterohepatic recycling.<span class="mw-ref" id="cite_ref-pmid10428318_2-10"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is metabolized exclusively by glucuronidation and is not metabolized by the cytochrome P450 system.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-17"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-11"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Less than 1% of radiolabeled material in plasma comprises unconjugated raloxifene.<span class="mw-ref" id="cite_ref-pmid10428318_2-12"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The metabolites of raloxifene include several glucuronides.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-18"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The elimination half-life of raloxifene after a single dose is 27.7<span>&nbsp;</span>hours (1.2<span>&nbsp;</span>days), whereas its half-life at steady state at a dosage of 60<span>&nbsp;</span>mg/day is 15.8 to 86.6<span>&nbsp;</span>hours (0.7–3.6<span>&nbsp;</span>days), with an average of 32.5<span>&nbsp;</span>hours (1.4<span>&nbsp;</span>days).<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-19"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-13"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The extended half-life of raloxifene is attributed to enterohepatic recirculation and its high plasma protein binding.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-20"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Raloxifene and its glucuronide conjugates are interconverted by reversible metabolism and enterohepatic recycling, which prolongs the elimination half-life of raloxifene with oral administration.<span class="mw-ref" id="cite_ref-pmid10428318_2-14"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The medication is deconjugated into its active form in a variety of tissues, including liver, lungs, spleen, bone, uterus, and kidneys.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-21"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Elimination">Elimination</h4></summary>
    
<p>Raloxifene is mainly excreted in bile and is eliminated in feces.<span class="mw-ref" id="cite_ref-MorelloWurz2003_1-22"><a href="#cite_note-MorelloWurz2003-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid10428318_2-15"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Less than 0.2% of a dose is excreted unchanged in urine and less than 6% of a dose is excreted in urine as glucuronide conjugates.<span class="mw-ref" id="cite_ref-pmid10428318_2-16"><a href="#cite_note-pmid10428318-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div role="note" class="hatnote navigation-not-searchable">See also: List of selective estrogen receptor modulators and <a href="Benzothiophene.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzothiophene" title="Benzothiophene">Benzothiophene</a></div>

<p>Raloxifene hydrochloride has the empirical formula C<sub>28</sub>H<sub>27</sub>NO<sub>4</sub>S•HCl, which corresponds to a molecular weight of 510.05 g/mol. Raloxifene hydrochloride is an off-white to pale-yellow solid that is slightly soluble in water.<span class="mw-ref" id="cite_ref-Label_14-3"><a href="#cite_note-Label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Raloxifene is a <a href="Benzothiophene.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzothiophene" title="Benzothiophene">benzothiophene</a> derivative and is structurally distinct from the triphenylethylene SERMs like <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a>, and <a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">toremifene</a>.<span class="mw-ref" id="cite_ref-OrwollBliziotes2002_37-0"><a href="#cite_note-OrwollBliziotes2002-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> It is the only benzothiophene SERM to have been marketed.<span class="mw-ref" id="cite_ref-OrwollBliziotes2002_37-1"><a href="#cite_note-OrwollBliziotes2002-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> A benzothiophene SERM that was not marketed is arzoxifene (LY-353381).<span class="mw-ref" id="cite_ref-SilvermanAbrahamsen2015_38-0"><a href="#cite_note-SilvermanAbrahamsen2015-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Bazedoxifene (Duavee, Viviant) and pipendoxifene (ERA-923) are structurally related to raloxifene but are technically not benzothiophenes and instead are <a href="Indole.htm" tppabs="https://ptable.com/wiki/compounds/A/Indole" title="Indole">indoles</a>.<span class="mw-ref" id="cite_ref-SilvermanAbrahamsen2015_38-1"><a href="#cite_note-SilvermanAbrahamsen2015-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Raloxifene was approved in the United States for the prevention of postmenopausal osteoporosis in 1997, the treatment of postmenopausal osteoporosis in 1999, and to prevent or reduce the risk of breast cancer in certain postmenopausal women in 2007.<span class="mw-ref" id="cite_ref-MedicinePolicy2011_39-0"><a href="#cite_note-MedicinePolicy2011-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-AmCnclonScience2011_40-0"><a href="#cite_note-AmCnclonScience2011-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-Bonnick2007_41-0"><a href="#cite_note-Bonnick2007-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-LiJohnson2013_42-0"><a href="#cite_note-LiJohnson2013-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> It received orphan designation in 2005.<span class="mw-ref" id="cite_ref-MedicinePolicy2011_39-1"><a href="#cite_note-MedicinePolicy2011-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:202px"><img src="../I/m/Rolaxifene.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Rolaxifene.jpg" data-file-width="1461" data-file-height="1770" data-file-type="bitmap" height="242" width="200"><div class="thumbcaption" style="text-align: left">A bottle of raloxifene.</div></div></div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Names">Names</h3></summary>
    
<p><i>Raloxifene</i> is the generic name of the drug and its <abbr>INN</abbr> and <abbr>BAN</abbr>, while <i>raloxifène</i> is its <abbr>DCF</abbr> and <i>raloxifene hydrochloride</i> is its <abbr>USAN</abbr>, <abbr>BANM</abbr>, and <abbr>JAN</abbr>.<span class="mw-ref" id="cite_ref-Elks2014_43-0"><a href="#cite_note-Elks2014-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_44-0"><a href="#cite_note-IndexNominum2000-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall1999_45-0"><a href="#cite_note-MortonHall1999-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_46-0"><a href="#cite_note-Drugs.com-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> It has also been known by the name <i>keoxifene</i>.<span class="mw-ref" id="cite_ref-Elks2014_43-1"><a href="#cite_note-Elks2014-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_44-1"><a href="#cite_note-IndexNominum2000-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_46-1"><a href="#cite_note-Drugs.com-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>

<p>Raloxifene is sold mainly under the brand name Evista and to a lesser extent the brand name Optruma.<span class="mw-ref" id="cite_ref-Drugs.com_46-2"><a href="#cite_note-Drugs.com-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_44-2"><a href="#cite_note-IndexNominum2000-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> It is also sold under a variety of other brand names in various countries.<span class="mw-ref" id="cite_ref-Drugs.com_46-3"><a href="#cite_note-Drugs.com-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    
<p>Raloxifene is available widely throughout the world, including in the United States, Canada, the United Kingdom, Ireland, elsewhere throughout Europe, Australia, New Zealand, South Africa, Latin America, Southern, Eastern, and Southeastern Asia, and elsewhere in the world such as in Israel and Egypt.<span class="mw-ref" id="cite_ref-Drugs.com_46-4"><a href="#cite_note-Drugs.com-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_44-3"><a href="#cite_note-IndexNominum2000-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>

<p>Raloxifene is provided in the form of 60<span>&nbsp;</span>mg oral tablets.<span class="mw-ref" id="cite_ref-Mosby2013_10-2"><a href="#cite_note-Mosby2013-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Controversy">Controversy</h3></summary>
    
<p>An editorial in Lancet Oncology criticized the way that research about the medication for breast cancer prevention was released.<span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Clinical studies of raloxifene for metastatic breast cancer in women have been conducted but found little effectiveness at 60<span>&nbsp;</span>mg/day in those previously treated with tamoxifen, though modest effectiveness has been observed at higher doses.<span class="mw-ref" id="cite_ref-pmid15755972_12-19"><a href="#cite_note-pmid15755972-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-pmid27583816_48-0"><a href="#cite_note-pmid27583816-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> In contrast to tamoxifen, raloxifene is not approved for the treatment of breast cancer.<span class="mw-ref" id="cite_ref-HollandPollock2010_49-0"><a href="#cite_note-HollandPollock2010-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>

<p>Raloxifene has been studied in men for a variety of uses, such as for treatment of schizophrenia, prostate cancer, and osteoporosis.<span class="mw-ref" id="cite_ref-pmid10856400_50-0"><a href="#cite_note-pmid10856400-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-pmid11697809_51-0"><a href="#cite_note-pmid11697809-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-pmid15080777_52-0"><a href="#cite_note-pmid15080777-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid15080785_53-0"><a href="#cite_note-pmid15080785-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-pmid15292315_54-0"><a href="#cite_note-pmid15292315-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-pmid15312253_33-1"><a href="#cite_note-pmid15312253-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-pmid22319035_32-1"><a href="#cite_note-pmid22319035-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid27771244_55-0"><a href="#cite_note-pmid27771244-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-pmid26069170_56-0"><a href="#cite_note-pmid26069170-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-pmid25980345_57-0"><a href="#cite_note-pmid25980345-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-FujimuraTakayama2018_58-0"><a href="#cite_note-FujimuraTakayama2018-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> It has been studied in combination with castration and <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a>, a nonsteroidal antiandrogen, for the treatment of prostate cancer.<span class="mw-ref" id="cite_ref-FujimuraTakayama2018_58-1"><a href="#cite_note-FujimuraTakayama2018-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-pmid27771244_55-1"><a href="#cite_note-pmid27771244-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>Raloxifene has been studied as an adjunct in the treatment of schizophrenia in postmenopausal women.<span class="mw-ref" id="cite_ref-pmid28849318_59-0"><a href="#cite_note-pmid28849318-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> A 2017 meta-analysis concluded that it was safe and effective for this indication, although further studies with larger sample sizes are needed for confirmation.<span class="mw-ref" id="cite_ref-pmid28849318_59-1"><a href="#cite_note-pmid28849318-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> It may be effective in women with less severe symptoms.<span class="mw-ref" id="cite_ref-pmid28849318_59-2"><a href="#cite_note-pmid28849318-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>

<p>A tissue-selective estrogen-receptor complex (TSEC) of estradiol and raloxifene has been studied in postmenopausal women.<span class="mw-ref" id="cite_ref-pmid22549172_60-0"><a href="#cite_note-pmid22549172-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>

<p>Raloxifene (60<span>&nbsp;</span>mg/day) was reported to be effective in the treatment of pubertal gynecomastia in adolescent boys in a small retrospective chart review.<span class="mw-ref" id="cite_ref-pmid18622190_61-0"><a href="#cite_note-pmid18622190-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-pmid28260521_62-0"><a href="#cite_note-pmid28260521-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-pmid15238910_63-0"><a href="#cite_note-pmid15238910-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Other SERMs are also known to be effective in the treatment of gynecomastia.<span class="mw-ref" id="cite_ref-KanakisNordkap2019_64-0"><a href="#cite_note-KanakisNordkap2019-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>

<p>Raloxifene has been reported to augment the antidepressant effects of selective serotonin reuptake inhibitors (SSRIs).<span class="mw-ref" id="cite_ref-SugiyamaBarros2010_65-0"><a href="#cite_note-SugiyamaBarros2010-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></p>

<p>June 18th 2020, <a href="javascript:if(confirm('https://www.exscalate4cov.eu/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.exscalate4cov.eu/'" tppabs="https://www.exscalate4cov.eu/" class="external text external">Exscalate4CoV</a>, the private-public consortium supported by the EU’s Horizon 2020 programme for research and innovation, led by <a href="javascript:if(confirm('https://www.dompe.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.dompe.com/'" tppabs="https://www.dompe.com/" class="external text external">Dompé farmaceutici</a> and currently representing 18 partners (including <a href="javascript:if(confirm('https://www.ime.fraunhofer.de/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ime.fraunhofer.de/'" tppabs="https://www.ime.fraunhofer.de/" class="external text external">Fraunhofer Institute</a>, <a href="javascript:if(confirm('https://www.cineca.it/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cineca.it/'" tppabs="https://www.cineca.it/" class="external text external">CINECA</a>, <a href="javascript:if(confirm('https://www.chelonia.swiss/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.chelonia.swiss/'" tppabs="https://www.chelonia.swiss/" class="external text external">Chelonia Applied Science</a>, <a href="javascript:if(confirm('https://www.sib.swiss/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sib.swiss/'" tppabs="https://www.sib.swiss/" class="external text external">Swiss Institute of Bioinformatics</a> and others) has requested access to clinical trials for the use of Raloxifene in Covid 19 patients. Raloxifene, already proven effective against Mers and Sars in precliinical tests, has been indicated as effective against Sars-Cov2 by the “in-silico” research conducted by the consortium which has shown efficacy in countering the replication of the virus in cells. The IP for its use against Sars-Cov2 has already been protected on May 6 2020 in the name Dompé farmaceutici, Fraunhofer Institute and KU Leuven, to facilitate the largest possible access. Raloxifene would be used in mildly symptomatic Covid19 patients to halt the spread of infection. This result emerged from the first virtual (in silico) screening conducted on the Consortium’s supercomputers of more than 400.000 molecules (safe-in-man drugs and natural products) made available by Dompé farmaceutici and the partner Fraunhofer (IME) to the Consortium. The molecules were prioritized if in clinical stage or already on the market. 7.000 molecules with certain promising characteristics were tested.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-MorelloWurz2003-1"> <span id="mw-reference-text-cite_note-MorelloWurz2003-1" class="mw-reference-text"><cite id="CITEREFMorelloWurzDeGregorio2003" class="citation journal cs1">Morello, Karla C.; Wurz, Gregory T.; DeGregorio, Michael W. (2003). "Pharmacokinetics of Selective Estrogen Receptor Modulators". <i>Clinical Pharmacokinetics</i>. <b>42</b> (4): 361–372. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200342040-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200342040-00004'" tppabs="https://doi.org/10.2165%2F00003088-200342040-00004" class="external text external">10.2165/00003088-200342040-00004</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0312-5963  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0312-5963'" tppabs="https://www.worldcat.org/issn/0312-5963" class="external text external">0312-5963</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12648026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12648026'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12648026" class="external text external">12648026</a>.</cite></span></li><li id="cite_note-pmid10428318-2"> <span id="mw-reference-text-cite_note-pmid10428318-2" class="mw-reference-text"><cite id="CITEREFHochner-Celnikier1999" class="citation journal cs1">Hochner-Celnikier D (1999). "Pharmacokinetics of raloxifene and its clinical application". <i>Eur. J. Obstet. Gynecol. Reprod. Biol</i>. <b>85</b> (1): 23–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0301-2115%2898%2900278-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0301-2115%2898%2900278-4'" tppabs="https://doi.org/10.1016%2Fs0301-2115%2898%2900278-4" class="external text external">10.1016/s0301-2115(98)00278-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10428318  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10428318'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10428318" class="external text external">10428318</a>.</cite></span></li><li id="cite_note-Jeong-3"> <span id="mw-reference-text-cite_note-Jeong-3" class="mw-reference-text"><cite id="CITEREFJeongLiu,_YongLin,_HuiminHu,_Ming2005" class="citation journal cs1">Jeong, Eun Ju; Liu, Yong; Lin, Huimin; Hu, Ming (2005-03-15). "Species- and Disposition Model-Dependent Metabolism of Raloxifene in Gut and Liver: Role of UGT1A10". <i>Drug Metabolism and Disposition</i>. ASPET. <b>33</b> (6): 785–794. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fdmd.104.001883  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fdmd.104.001883'" tppabs="https://doi.org/10.1124%2Fdmd.104.001883" class="external text external">10.1124/dmd.104.001883</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15769887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15769887'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15769887" class="external text external">15769887</a>.</cite></span></li><li id="cite_note-AHFS2019-4"> <span id="mw-reference-text-cite_note-AHFS2019-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/raloxifene-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/raloxifene-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/raloxifene-hydrochloride.html" class="external text external">"Raloxifene Hydrochloride Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">22 March</span> 2019</span>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFYangYuZhang2013" class="citation journal cs1">Yang, Z. D.; Yu, J.; Zhang, Q. (August 2013). "Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials". <i>Maturitas</i>. <b>75</b> (4): 341–348. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2013.05.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2013.05.010'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2013.05.010" class="external text external">10.1016/j.maturitas.2013.05.010</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1873-4111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1873-4111'" tppabs="https://www.worldcat.org/issn/1873-4111" class="external text external">1873-4111</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23764354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23764354'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23764354" class="external text external">23764354</a>.</cite></span></li><li id="cite_note-BNF76-6"> <span id="mw-reference-text-cite_note-BNF76-6" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. pp.<span>&nbsp;</span>736–737. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-NADAC2019-7"> <span id="mw-reference-text-cite_note-NADAC2019-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6" class="external text external">"NADAC as of 2019-02-27"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/RaloxifeneHydrochloride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/RaloxifeneHydrochloride'" tppabs="https://clincalc.com/DrugStats/Drugs/RaloxifeneHydrochloride" class="external text external">"Raloxifene Hydrochloride - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-:0-9"> <span id="mw-reference-text-cite_note-:0-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a698007.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a698007.html'" tppabs="https://medlineplus.gov/druginfo/meds/a698007.html" class="external text external">"Raloxifene: MedlinePlus Drug Information"</a>. <i>medlineplus.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-11-07</span></span>.</cite></span></li><li id="cite_note-Mosby2013-10"> <span id="mw-reference-text-cite_note-Mosby2013-10" class="mw-reference-text"><cite id="CITEREFMosby2013" class="citation book cs1">Mosby (5 March 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=41z07XtCfa0C&pg=PA1379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=41z07XtCfa0C&pg=PA1379'" tppabs="https://books.google.com/books?id=41z07XtCfa0C&pg=PA1379" class="external text external"><i>Mosby's Drug Reference for Health Professions - E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>1379–. ISBN<span>&nbsp;</span><bdi>978-0-323-18760-2</bdi>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFOhtaHamayaTaketsunaSowa2015" class="citation journal cs1">Ohta, Hiroaki; Hamaya, Etsuro; Taketsuna, Masanori; Sowa, Hideaki (January 2015). "Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing study". <i>Current Medical Research and Opinion</i>. <b>31</b> (1): 85–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F03007995.2014.975339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F03007995.2014.975339'" tppabs="https://doi.org/10.1185%2F03007995.2014.975339" class="external text external">10.1185/03007995.2014.975339</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1473-4877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1473-4877'" tppabs="https://www.worldcat.org/issn/1473-4877" class="external text external">1473-4877</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25299349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25299349'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25299349" class="external text external">25299349</a>.</cite></span></li><li id="cite_note-pmid15755972-12"> <span id="mw-reference-text-cite_note-pmid15755972-12" class="mw-reference-text"><cite id="CITEREFFabianKimler2005" class="citation journal cs1">Fabian CJ, Kimler BF (March 2005). "Selective estrogen-receptor modulators for primary prevention of breast cancer". <i>J. Clin. Oncol</i>. <b>23</b> (8): 1644–55. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2005.11.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2005.11.005'" tppabs="https://doi.org/10.1200%2FJCO.2005.11.005" class="external text external">10.1200/JCO.2005.11.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15755972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15755972'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15755972" class="external text external">15755972</a>.</cite></span></li><li id="cite_note-BlandCopeland2017-13"> <span id="mw-reference-text-cite_note-BlandCopeland2017-13" class="mw-reference-text"><cite id="CITEREFKirby_I._BlandEdward_M._CopelandV._Suzanne_KlimbergWilliam_J_Gradishar2017" class="citation book cs1">Kirby I. Bland; Edward M. Copeland; V. Suzanne Klimberg; William J Gradishar (29 June 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=hJwqDwAAQBAJ&pg=PA231  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=hJwqDwAAQBAJ&pg=PA231'" tppabs="https://books.google.com/books?id=hJwqDwAAQBAJ&pg=PA231" class="external text external"><i>The Breast E-Book: Comprehensive Management of Benign and Malignant Diseases</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>231–. ISBN<span>&nbsp;</span><bdi>978-0-323-51187-2</bdi>.</cite></span></li><li id="cite_note-Label-14"> <span id="mw-reference-text-cite_note-Label-14" class="mw-reference-text"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022042lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022042lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022042lbl.pdf" class="external text external">Raloxifene label</a> Last updated 09/2007]</span></li><li id="cite_note-pmid23942473-15"> <span id="mw-reference-text-cite_note-pmid23942473-15" class="mw-reference-text"><cite id="CITEREFGizzoSaccardiPatrelliBerretta2013" class="citation journal cs1">Gizzo S, Saccardi C, Patrelli TS, Berretta R, Capobianco G, Di Gangi S, Vacilotto A, Bertocco A, Noventa M, Ancona E, D'Antona D, Nardelli GB (2013). "Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications". <i>Obstet Gynecol Surv</i>. <b>68</b> (6): 467–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FOGX.0b013e31828baef9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FOGX.0b013e31828baef9'" tppabs="https://doi.org/10.1097%2FOGX.0b013e31828baef9" class="external text external">10.1097/OGX.0b013e31828baef9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23942473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23942473'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23942473" class="external text external">23942473</a>.</cite></span></li><li id="cite_note-Goldstein2000-16"> <span id="mw-reference-text-cite_note-Goldstein2000-16" class="mw-reference-text"><cite id="CITEREFGoldstein2000" class="citation journal cs1">Goldstein, S. R. (2000). <a href="javascript:if(confirm('https://doi.org/10.1093/humupd/6.3.212  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/humupd/6.3.212'" tppabs="https://doi.org/10.1093/humupd/6.3.212" class="external text external">"A pharmacological review of selective oestrogen receptor modulators"</a>. <i>Human Reproduction Update</i>. <b>6</b> (3): 212–224. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fhumupd%2F6.3.212  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fhumupd%2F6.3.212'" tppabs="https://doi.org/10.1093%2Fhumupd%2F6.3.212" class="external text external">10.1093/humupd/6.3.212</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1355-4786  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1355-4786'" tppabs="https://www.worldcat.org/issn/1355-4786" class="external text external">1355-4786</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10874566  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10874566'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10874566" class="external text external">10874566</a>.</cite></span></li><li id="cite_note-pmid11281162-17"> <span id="mw-reference-text-cite_note-pmid11281162-17" class="mw-reference-text"><cite id="CITEREFSeeman2001" class="citation journal cs1">Seeman E (2001). "Raloxifene". <i>J. Bone Miner. Metab</i>. <b>19</b> (2): 65–75. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs007740170043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs007740170043'" tppabs="https://doi.org/10.1007%2Fs007740170043" class="external text external">10.1007/s007740170043</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11281162  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11281162'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11281162" class="external text external">11281162</a>.</cite></span></li><li id="cite_note-Park2002-18"> <span id="mw-reference-text-cite_note-Park2002-18" class="mw-reference-text"><cite id="CITEREFPark2002" class="citation journal cs1">Park, W (2002). "Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention". <i>Trends in Molecular Medicine</i>. <b>8</b> (2): 82–88. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1471-4914%2802%2902282-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1471-4914%2802%2902282-7'" tppabs="https://doi.org/10.1016%2FS1471-4914%2802%2902282-7" class="external text external">10.1016/S1471-4914(02)02282-7</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1471-4914  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1471-4914'" tppabs="https://www.worldcat.org/issn/1471-4914" class="external text external">1471-4914</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11815274  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11815274'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11815274" class="external text external">11815274</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFAgency_for_Healthcare_Research_and_Quality,_Rockville,_MD.2009" class="citation web cs1">Agency for Healthcare Research and Quality, Rockville, MD. (September 2009). <a href="javascript:if(confirm('http://archive.ahrq.gov/news/newsroom/press-releases/2009/brcanmed.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://archive.ahrq.gov/news/newsroom/press-releases/2009/brcanmed.html'" tppabs="http://archive.ahrq.gov/news/newsroom/press-releases/2009/brcanmed.html" class="external text external">"Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-09-14</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Lemmo2016-20"> <span id="mw-reference-text-cite_note-Lemmo2016-20" class="mw-reference-text"><cite id="CITEREFLemmo2016" class="citation journal cs1">Lemmo, W (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739193  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739193'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739193" class="external text external">"Anti-Estrogen Withdrawal Effect With Raloxifene? A Case Report"</a>. <i>Integrative Cancer Therapies</i>. Published Online Before Print July 13 (3): 245–249. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1534735416658954  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1534735416658954'" tppabs="https://doi.org/10.1177%2F1534735416658954" class="external text external">10.1177/1534735416658954</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739193  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739193'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739193" class="external text external">5739193</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27411856  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27411856'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27411856" class="external text external">27411856</a>.</cite></span></li><li id="cite_note-Haskell2003-21"> <span id="mw-reference-text-cite_note-Haskell2003-21" class="mw-reference-text"><cite id="CITEREFHaskell2003" class="citation journal cs1">Haskell, Sally G. (2003). "Selective Estrogen Receptor Modulators". <i>Southern Medical Journal</i>. <b>96</b> (5): 469–476. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.SMJ.0000051146.93190.4A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.SMJ.0000051146.93190.4A'" tppabs="https://doi.org/10.1097%2F01.SMJ.0000051146.93190.4A" class="external text external">10.1097/01.SMJ.0000051146.93190.4A</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0038-4348  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0038-4348'" tppabs="https://www.worldcat.org/issn/0038-4348" class="external text external">0038-4348</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12911186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12911186'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12911186" class="external text external">12911186</a>.</cite></span></li><li id="cite_note-WeathermanClegg2001-22"> <span id="mw-reference-text-cite_note-WeathermanClegg2001-22" class="mw-reference-text"><cite id="CITEREFWeathermanCleggScanlan2001" class="citation journal cs1">Weatherman, Ross V; Clegg, Nicola J; Scanlan, Thomas S (2001). <a href="javascript:if(confirm('https://doi.org/10.1016/S1074-5521(01)00025-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/S1074-5521(01)00025-4'" tppabs="https://doi.org/10.1016/S1074-5521(01)00025-4" class="external text external">"Differential SERM activation of the estrogen receptors (ERα and ERβ) at AP-1 sites"</a>. <i>Chemistry &amp; Biology</i>. <b>8</b> (5): 427–436. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2FS1074-5521%2801%2900025-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1074-5521%2801%2900025-4'" tppabs="https://doi.org/10.1016%2FS1074-5521%2801%2900025-4" class="external text external">10.1016/S1074-5521(01)00025-4</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1074-5521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1074-5521'" tppabs="https://www.worldcat.org/issn/1074-5521" class="external text external">1074-5521</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11358690  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11358690'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11358690" class="external text external">11358690</a>.</cite></span></li><li id="cite_note-pmid16554039-23"> <span id="mw-reference-text-cite_note-pmid16554039-23" class="mw-reference-text"><cite id="CITEREFEscandePillonServantCravedi2006" class="citation journal cs1">Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P (May 2006). "Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta". <i>Biochem. Pharmacol</i>. <b>71</b> (10): 1459–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bcp.2006.02.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bcp.2006.02.002'" tppabs="https://doi.org/10.1016%2Fj.bcp.2006.02.002" class="external text external">10.1016/j.bcp.2006.02.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16554039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16554039'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16554039" class="external text external">16554039</a>.</cite></span></li><li id="cite_note-GreeneShiau2004-24"> <span id="mw-reference-text-cite_note-GreeneShiau2004-24" class="mw-reference-text"><cite id="CITEREFGreeneShiauNettles2004" class="citation journal cs1">Greene, G. L.; Shiau, A. K.; Nettles, K. W. (2004). "A Structural Explanation for ERα/ERβ SERM Discrimination". <i>New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives in Estrogen Therapy</i> (46): 33–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-662-05386-7_3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-662-05386-7_3'" tppabs="https://doi.org/10.1007%2F978-3-662-05386-7_3" class="external text external">10.1007/978-3-662-05386-7_3</a>. ISBN<span>&nbsp;</span><bdi>978-3-662-05388-1</bdi>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15248503  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15248503'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15248503" class="external text external">15248503</a>.</cite></span></li><li id="cite_note-BarkhemCarlsson1998-25"> <span id="mw-reference-text-cite_note-BarkhemCarlsson1998-25" class="mw-reference-text"><cite id="CITEREFBarkhemCarlssonNilssonEnmark1998" class="citation journal cs1">Barkhem, Tomas; Carlsson, Bo; Nilsson, Yvonne; Enmark, Eva; Gustafsson, Jan-Åke; Nilsson, Stefan (1998). "Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists". <i>Molecular Pharmacology</i>. <b>54</b> (1): 105–112. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fmol.54.1.105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fmol.54.1.105'" tppabs="https://doi.org/10.1124%2Fmol.54.1.105" class="external text external">10.1124/mol.54.1.105</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0026-895X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0026-895X'" tppabs="https://www.worldcat.org/issn/0026-895X" class="external text external">0026-895X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9658195  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9658195'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9658195" class="external text external">9658195</a>.</cite></span></li><li id="cite_note-pmid26023144-26"> <span id="mw-reference-text-cite_note-pmid26023144-26" class="mw-reference-text"><cite id="CITEREFProssnitzArterburn2015" class="citation journal cs1">Prossnitz ER, Arterburn JB (July 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017" class="external text external">"International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators"</a>. <i>Pharmacol. Rev</i>. <b>67</b> (3): 505–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fpr.114.009712  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fpr.114.009712'" tppabs="https://doi.org/10.1124%2Fpr.114.009712" class="external text external">10.1124/pr.114.009712</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017" class="external text external">4485017</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26023144  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26023144'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26023144" class="external text external">26023144</a>.</cite></span></li><li id="cite_note-pmid24379833-27"> <span id="mw-reference-text-cite_note-pmid24379833-27" class="mw-reference-text"><cite id="CITEREFPetrieDennisHuDai2013" class="citation journal cs1">Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, Hathaway HJ, Prossnitz ER (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863501'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863501" class="external text external">"G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth"</a>. <i>Obstet Gynecol Int</i>. <b>2013</b>: 472720. doi:<a href="javascript:if(confirm('https://doi.org/10.1155%2F2013%2F472720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2F2013%2F472720'" tppabs="https://doi.org/10.1155%2F2013%2F472720" class="external text external">10.1155/2013/472720</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863501'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863501" class="external text external">3863501</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24379833  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24379833'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24379833" class="external text external">24379833</a>.</cite></span></li><li id="cite_note-pmid20832226-28"> <span id="mw-reference-text-cite_note-pmid20832226-28" class="mw-reference-text"><cite id="CITEREFJeon-Hor,_Chen2003" class="citation journal cs1">Jeon-Hor, Chen;  et al. (September 15, 2003). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005955  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005955'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005955" class="external text external">"Reduction of Breast Density Following Tamoxifen Treatment Evaluated by 3-D MRI: Preliminary Study"</a>. <i>Magn Reson Imaging</i>. <b>29</b> (1): 91–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.mri.2010.07.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.mri.2010.07.009'" tppabs="https://doi.org/10.1016%2Fj.mri.2010.07.009" class="external text external">10.1016/j.mri.2010.07.009</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005955  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005955'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005955" class="external text external">3005955</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20832226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20832226'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20832226" class="external text external">20832226</a>.</cite></span></li><li id="cite_note-DraperChin2003-29"> <span id="mw-reference-text-cite_note-DraperChin2003-29" class="mw-reference-text"><cite id="CITEREFDraperChin2003" class="citation journal cs1">Draper, Michael W.; Chin, William W. (2003). "Molecular and Clinical Evidence for the Unique Nature of Individual Selective Estrogen Receptor Modulators". <i>Clinical Obstetrics and Gynecology</i>. <b>46</b> (2): 265–297. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00003081-200306000-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00003081-200306000-00008'" tppabs="https://doi.org/10.1097%2F00003081-200306000-00008" class="external text external">10.1097/00003081-200306000-00008</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0009-9201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0009-9201'" tppabs="https://www.worldcat.org/issn/0009-9201" class="external text external">0009-9201</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12808380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12808380'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12808380" class="external text external">12808380</a>.</cite></span></li><li id="cite_note-pmid25523084-30"> <span id="mw-reference-text-cite_note-pmid25523084-30" class="mw-reference-text"><cite id="CITEREFCoronaRastrelliRatrelliMaggi2015" class="citation journal cs1">Corona G, Rastrelli G, Ratrelli G, Maggi M (February 2015). "The pharmacotherapy of male hypogonadism besides androgens". <i>Expert Opin Pharmacother</i>. <b>16</b> (3): 369–87. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2015.993607  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2015.993607'" tppabs="https://doi.org/10.1517%2F14656566.2015.993607" class="external text external">10.1517/14656566.2015.993607</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25523084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25523084'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25523084" class="external text external">25523084</a>.</cite></span></li><li id="cite_note-pmid27704479-31"> <span id="mw-reference-text-cite_note-pmid27704479-31" class="mw-reference-text"><cite id="CITEREFDuarteJalladBronstein2016" class="citation journal cs1">Duarte FH, Jallad RS, Bronstein MD (November 2016). "Estrogens and selective estrogen receptor modulators in acromegaly". <i>Endocrine</i>. <b>54</b> (2): 306–314. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12020-016-1118-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12020-016-1118-z'" tppabs="https://doi.org/10.1007%2Fs12020-016-1118-z" class="external text external">10.1007/s12020-016-1118-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27704479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27704479'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27704479" class="external text external">27704479</a>.</cite></span></li><li id="cite_note-pmid22319035-32"> <span id="mw-reference-text-cite_note-pmid22319035-32" class="mw-reference-text"><cite id="CITEREFBirznieceSutantoHo2012" class="citation journal cs1">Birzniece V, Sutanto S, Ho KK (April 2012). <a href="javascript:if(confirm('https://doi.org/10.1210/jc.2011-3347  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/jc.2011-3347'" tppabs="https://doi.org/10.1210/jc.2011-3347" class="external text external">"Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators"</a>. <i>J. Clin. Endocrinol. Metab</i>. <b>97</b> (4): E521–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fjc.2011-3347  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjc.2011-3347'" tppabs="https://doi.org/10.1210%2Fjc.2011-3347" class="external text external">10.1210/jc.2011-3347</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22319035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22319035'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22319035" class="external text external">22319035</a>.</cite></span></li><li id="cite_note-pmid15312253-33"> <span id="mw-reference-text-cite_note-pmid15312253-33" class="mw-reference-text"><cite id="CITEREFUebelhartHerrmannPavoDraper2004" class="citation journal cs1">Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R (September 2004). "Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels". <i>J. Bone Miner. Res</i>. <b>19</b> (9): 1518–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1359%2FJBMR.040503  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1359%2FJBMR.040503'" tppabs="https://doi.org/10.1359%2FJBMR.040503" class="external text external">10.1359/JBMR.040503</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15312253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15312253'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15312253" class="external text external">15312253</a>.</cite></span></li><li id="cite_note-XuLovre2016-34"> <span id="mw-reference-text-cite_note-XuLovre2016-34" class="mw-reference-text"><cite id="CITEREFXuLovreMauvais-Jarvis2016" class="citation journal cs1">Xu, Beibei; Lovre, Dragana; Mauvais-Jarvis, Franck (2016). "Effect of selective estrogen receptor modulators on metabolic homeostasis". <i>Biochimie</i>. <b>124</b>: 92–97. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biochi.2015.06.018  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biochi.2015.06.018'" tppabs="https://doi.org/10.1016%2Fj.biochi.2015.06.018" class="external text external">10.1016/j.biochi.2015.06.018</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0300-9084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0300-9084'" tppabs="https://www.worldcat.org/issn/0300-9084" class="external text external">0300-9084</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26133657  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26133657'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26133657" class="external text external">26133657</a>. <q>In healthy postmemopausal women, raloxifene treatment for one year prevented body weight gain and abdominal adiposity by promoting a shift from an android to gynoid fat distribution [46].</q></cite></span></li><li id="cite_note-FrancucciPantaleo2014-35"> <span id="mw-reference-text-cite_note-FrancucciPantaleo2014-35" class="mw-reference-text"><cite id="CITEREFFrancucciPantaleoIoriCamilletti2014" class="citation journal cs1">Francucci, C. M.; Pantaleo, D.; Iori, N.; Camilletti, A.; Massi, F.; Boscaro, M. (2014). "Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women". <i>Journal of Endocrinological Investigation</i>. <b>28</b> (9): 623–631. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF03347261  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF03347261'" tppabs="https://doi.org/10.1007%2FBF03347261" class="external text external">10.1007/BF03347261</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0391-4097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0391-4097'" tppabs="https://www.worldcat.org/issn/0391-4097" class="external text external">0391-4097</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16218045  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16218045'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16218045" class="external text external">16218045</a>. <q>These results [...] suggest, for the first time, that RLX promotes the shift from android to gynoid fat distribution, and prevents the uptrend of abdominal adiposity and body weight compared with untreated women.</q></cite></span></li><li id="cite_note-pmid11006795-36"> <span id="mw-reference-text-cite_note-pmid11006795-36" class="mw-reference-text"><cite id="CITEREFSnyderSparanoMalinowski2000" class="citation journal cs1">Snyder KR, Sparano N, Malinowski JM (September 2000). "Raloxifene hydrochloride". <i>Am J Health Syst Pharm</i>. <b>57</b> (18): 1669–75, quiz 1676–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fajhp%2F57.18.1669  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fajhp%2F57.18.1669'" tppabs="https://doi.org/10.1093%2Fajhp%2F57.18.1669" class="external text external">10.1093/ajhp/57.18.1669</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11006795  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11006795'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11006795" class="external text external">11006795</a>.</cite></span></li><li id="cite_note-OrwollBliziotes2002-37"> <span id="mw-reference-text-cite_note-OrwollBliziotes2002-37" class="mw-reference-text"><cite id="CITEREFEric_S._OrwollMichael_Bliziotes2002" class="citation book cs1">Eric S. Orwoll; Michael Bliziotes (2 August 2002). <a href="javascript:if(confirm('https://books.google.com/books?id=iX31BwAAQBAJ&pg=PA320  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=iX31BwAAQBAJ&pg=PA320'" tppabs="https://books.google.com/books?id=iX31BwAAQBAJ&pg=PA320" class="external text external"><i>Osteoporosis: Pathophysiology and Clinical Management</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>320–. ISBN<span>&nbsp;</span><bdi>978-1-59259-278-4</bdi>.</cite></span></li><li id="cite_note-SilvermanAbrahamsen2015-38"> <span id="mw-reference-text-cite_note-SilvermanAbrahamsen2015-38" class="mw-reference-text"><cite id="CITEREFStuart_SilvermanBo_Abrahamsen2015" class="citation book cs1">Stuart Silverman; Bo Abrahamsen (29 December 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=5bFPCwAAQBAJ&pg=PA24  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5bFPCwAAQBAJ&pg=PA24'" tppabs="https://books.google.com/books?id=5bFPCwAAQBAJ&pg=PA24" class="external text external"><i>The Duration and Safety of Osteoporosis Treatment: Anabolic and Antiresorptive Therapy</i></a>. Springer. pp.<span>&nbsp;</span>24–. ISBN<span>&nbsp;</span><bdi>978-3-319-23639-1</bdi>.</cite></span></li><li id="cite_note-MedicinePolicy2011-39"> <span id="mw-reference-text-cite_note-MedicinePolicy2011-39" class="mw-reference-text"><cite id="CITEREFInstitute_of_MedicineBoard_on_Health_Sciences_PolicyCommittee_on_Accelerating_Rare_Diseases_Research_and_Orphan_Product_Development2011" class="citation book cs1">Institute of Medicine; Board on Health Sciences Policy; Committee on Accelerating Rare Diseases Research and Orphan Product Development (3 April 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=HnYyeNIY3WwC&pg=PT113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=HnYyeNIY3WwC&pg=PT113'" tppabs="https://books.google.com/books?id=HnYyeNIY3WwC&pg=PT113" class="external text external"><i>Rare Diseases and Orphan Products: Accelerating Research and Development</i></a>. National Academies Press. pp.<span>&nbsp;</span>113–. ISBN<span>&nbsp;</span><bdi>978-0-309-15806-0</bdi>.</cite></span></li><li id="cite_note-AmCnclonScience2011-40"> <span id="mw-reference-text-cite_note-AmCnclonScience2011-40" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=jpNsg_Sx2wMC&pg=PA10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=jpNsg_Sx2wMC&pg=PA10'" tppabs="https://books.google.com/books?id=jpNsg_Sx2wMC&pg=PA10" class="external text external"><i>Reducing Breast Cancer Risk with Drugs</i></a>. Am Cncl on Science, Health. pp.<span>&nbsp;</span>10–. GGKEY:CBEALLAHP8W.</cite></span></li><li id="cite_note-Bonnick2007-41"> <span id="mw-reference-text-cite_note-Bonnick2007-41" class="mw-reference-text"><cite id="CITEREFSydney_Lou_Bonnick2007" class="citation book cs1">Sydney Lou Bonnick (10 November 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=0NGsgFAf_9QC&pg=PA277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0NGsgFAf_9QC&pg=PA277'" tppabs="https://books.google.com/books?id=0NGsgFAf_9QC&pg=PA277" class="external text external"><i>Bone Densitometry for Technologists</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>277–. ISBN<span>&nbsp;</span><bdi>978-1-59259-992-9</bdi>.</cite></span></li><li id="cite_note-LiJohnson2013-42"> <span id="mw-reference-text-cite_note-LiJohnson2013-42" class="mw-reference-text"><cite id="CITEREFJie_Jack_LiDouglas_S._Johnson2013" class="citation book cs1">Jie Jack Li; Douglas S. Johnson (27 March 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=NtdT5maa_pMC&pg=RA2-PA73  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=NtdT5maa_pMC&pg=RA2-PA73'" tppabs="https://books.google.com/books?id=NtdT5maa_pMC&pg=RA2-PA73" class="external text external"><i>Modern Drug Synthesis</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>2–. ISBN<span>&nbsp;</span><bdi>978-1-118-70124-9</bdi>.</cite></span></li><li id="cite_note-Elks2014-43"> <span id="mw-reference-text-cite_note-Elks2014-43" class="mw-reference-text"><cite id="CITEREFJ._Elks2014" class="citation book cs1">J. Elks (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1063'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1063" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>1063–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-IndexNominum2000-44"> <span id="mw-reference-text-cite_note-IndexNominum2000-44" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA909'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA909" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. pp.<span>&nbsp;</span>909–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-MortonHall1999-45"> <span id="mw-reference-text-cite_note-MortonHall1999-45" class="mw-reference-text"><cite id="CITEREFI.K._MortonJudith_M._Hall1999" class="citation book cs1">I.K. Morton; Judith M. Hall (31 October 1999). <a href="javascript:if(confirm('https://books.google.com/books?id=mqaOMOtk61IC&pg=PA245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=mqaOMOtk61IC&pg=PA245'" tppabs="https://books.google.com/books?id=mqaOMOtk61IC&pg=PA245" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>245–. ISBN<span>&nbsp;</span><bdi>978-0-7514-0499-9</bdi>.</cite></span></li><li id="cite_note-Drugs.com-46"> <span id="mw-reference-text-cite_note-Drugs.com-46" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/raloxifene.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/raloxifene.html'" tppabs="https://www.drugs.com/international/raloxifene.html" class="external text external">"Raloxifene"</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFThelancetoncology2006" class="citation journal cs1">Thelancetoncology (2006). "A STARring role for raloxifene?". <i>Lancet Oncol</i>. <b>7</b> (6): 443. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1470-2045%2806%2970701-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1470-2045%2806%2970701-X'" tppabs="https://doi.org/10.1016%2FS1470-2045%2806%2970701-X" class="external text external">10.1016/S1470-2045(06)70701-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16750489  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16750489'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16750489" class="external text external">16750489</a>.</cite></span></li><li id="cite_note-pmid27583816-48"> <span id="mw-reference-text-cite_note-pmid27583816-48" class="mw-reference-text"><cite id="CITEREFProvincialiSuenDunnDeCensi2016" class="citation journal cs1">Provinciali N, Suen C, Dunn BK, DeCensi A (October 2016). "Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women". <i>Expert Rev Clin Pharmacol</i>. <b>9</b> (10): 1263–1272. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F17512433.2016.1231575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F17512433.2016.1231575'" tppabs="https://doi.org/10.1080%2F17512433.2016.1231575" class="external text external">10.1080/17512433.2016.1231575</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27583816  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27583816'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27583816" class="external text external">27583816</a>.</cite></span></li><li id="cite_note-HollandPollock2010-49"> <span id="mw-reference-text-cite_note-HollandPollock2010-49" class="mw-reference-text"><cite id="CITEREFJames_F._HollandRaphael_E._Pollock2010" class="citation book cs1">James F. Holland; Raphael E. Pollock (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=R0FbhLsWHBEC&pg=PA743  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=R0FbhLsWHBEC&pg=PA743'" tppabs="https://books.google.com/books?id=R0FbhLsWHBEC&pg=PA743" class="external text external"><i>Holland-Frei Cancer Medicine 8</i></a>. PMPH-USA. pp.<span>&nbsp;</span>743–. ISBN<span>&nbsp;</span><bdi>978-1-60795-014-1</bdi>.</cite></span></li><li id="cite_note-pmid10856400-50"> <span id="mw-reference-text-cite_note-pmid10856400-50" class="mw-reference-text"><cite id="CITEREFBlumHathawayMincemoyerSchenke2000" class="citation journal cs1">Blum A, Hathaway L, Mincemoyer R, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO (2000). "Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men". <i>Am. J. Cardiol</i>. <b>85</b> (12): 1491–4, A7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0002-9149%2800%2900802-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0002-9149%2800%2900802-x'" tppabs="https://doi.org/10.1016%2Fs0002-9149%2800%2900802-x" class="external text external">10.1016/s0002-9149(00)00802-x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10856400  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10856400'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10856400" class="external text external">10856400</a>.</cite></span></li><li id="cite_note-pmid11697809-51"> <span id="mw-reference-text-cite_note-pmid11697809-51" class="mw-reference-text"><cite id="CITEREFDoranRiggsAtkinsonKhosla2001" class="citation journal cs1">Doran PM, Riggs BL, Atkinson EJ, Khosla S (2001). "Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men". <i>J. Bone Miner. Res</i>. <b>16</b> (11): 2118–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1359%2Fjbmr.2001.16.11.2118  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1359%2Fjbmr.2001.16.11.2118'" tppabs="https://doi.org/10.1359%2Fjbmr.2001.16.11.2118" class="external text external">10.1359/jbmr.2001.16.11.2118</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11697809  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11697809'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11697809" class="external text external">11697809</a>.</cite></span></li><li id="cite_note-pmid15080777-52"> <span id="mw-reference-text-cite_note-pmid15080777-52" class="mw-reference-text"><cite id="CITEREFDimarakiSymonsBarkan2004" class="citation journal cs1">Dimaraki EV, Symons KV, Barkan AL (2004). <a href="javascript:if(confirm('https://doi.org/10.1530/eje.0.1500481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1530/eje.0.1500481'" tppabs="https://doi.org/10.1530/eje.0.1500481" class="external text external">"Raloxifene decreases serum IGF-I in male patients with active acromegaly"</a>. <i>Eur. J. Endocrinol</i>. <b>150</b> (4): 481–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1530%2Feje.0.1500481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1530%2Feje.0.1500481'" tppabs="https://doi.org/10.1530%2Feje.0.1500481" class="external text external">10.1530/eje.0.1500481</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15080777  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15080777'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15080777" class="external text external">15080777</a>.</cite></span></li><li id="cite_note-pmid15080785-53"> <span id="mw-reference-text-cite_note-pmid15080785-53" class="mw-reference-text"><cite id="CITEREFDuschekGoorenNetelenbos2004" class="citation journal cs1">Duschek EJ, Gooren LJ, Netelenbos C (2004). <a href="javascript:if(confirm('http://www.eje-online.org/content/150/4/539.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.eje-online.org/content/150/4/539.full.pdf'" tppabs="http://www.eje-online.org/content/150/4/539.full.pdf" class="external text external">"Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men"</a> <span class="cs1-format">(PDF)</span>. <i>Eur. J. Endocrinol</i>. <b>150</b> (4): 539–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1530%2Feje.0.1500539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1530%2Feje.0.1500539'" tppabs="https://doi.org/10.1530%2Feje.0.1500539" class="external text external">10.1530/eje.0.1500539</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15080785  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15080785'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15080785" class="external text external">15080785</a>.</cite></span></li><li id="cite_note-pmid15292315-54"> <span id="mw-reference-text-cite_note-pmid15292315-54" class="mw-reference-text"><cite id="CITEREFSmithFallonLeeFinkelstein2004" class="citation journal cs1">Smith MR, Fallon MA, Lee H, Finkelstein JS (2004). <a href="javascript:if(confirm('https://doi.org/10.1210/jc.2003-032058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/jc.2003-032058'" tppabs="https://doi.org/10.1210/jc.2003-032058" class="external text external">"Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial"</a>. <i>J. Clin. Endocrinol. Metab</i>. <b>89</b> (8): 3841–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fjc.2003-032058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjc.2003-032058'" tppabs="https://doi.org/10.1210%2Fjc.2003-032058" class="external text external">10.1210/jc.2003-032058</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15292315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15292315'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15292315" class="external text external">15292315</a>.</cite></span></li><li id="cite_note-pmid27771244-55"> <span id="mw-reference-text-cite_note-pmid27771244-55" class="mw-reference-text"><cite id="CITEREFHoNunez-NaterasHouBryce2017" class="citation journal cs1">Ho TH, Nunez-Nateras R, Hou YX, Bryce AH, Northfelt DW, Dueck AC, Wong B, Stanton ML, Joseph RW, Castle EP (2017). "A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer". <i>Clin Genitourin Cancer</i>. <b>15</b> (2): 196–202.e1. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clgc.2016.08.026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clgc.2016.08.026'" tppabs="https://doi.org/10.1016%2Fj.clgc.2016.08.026" class="external text external">10.1016/j.clgc.2016.08.026</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27771244  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27771244'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27771244" class="external text external">27771244</a>.</cite></span></li><li id="cite_note-pmid26069170-56"> <span id="mw-reference-text-cite_note-pmid26069170-56" class="mw-reference-text"><cite id="CITEREFKhodaie-ArdakaniKhosraviZarinfardNejati2015" class="citation journal cs1">Khodaie-Ardakani MR, Khosravi M, Zarinfard R, Nejati S, Mohsenian A, Tabrizi M, Akhondzadeh S (2015). "A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia". <i>Acta Med Iran</i>. <b>53</b> (6): 337–45. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26069170  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26069170'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26069170" class="external text external">26069170</a>.</cite></span></li><li id="cite_note-pmid25980345-57"> <span id="mw-reference-text-cite_note-pmid25980345-57" class="mw-reference-text"><cite id="CITEREFWeickertWeinbergLenrootCatts2015" class="citation journal cs1">Weickert TW, Weinberg D, Lenroot R, Catts SV, Wells R, Vercammen A, O'Donnell M, Galletly C, Liu D, Balzan R, Short B, Pellen D, Curtis J, Carr VJ, Kulkarni J, Schofield PR, Weickert CS (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444978  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444978'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444978" class="external text external">"Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia"</a>. <i>Mol. Psychiatry</i>. <b>20</b> (6): 685–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fmp.2015.11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fmp.2015.11'" tppabs="https://doi.org/10.1038%2Fmp.2015.11" class="external text external">10.1038/mp.2015.11</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444978  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444978'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444978" class="external text external">4444978</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25980345  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25980345'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25980345" class="external text external">25980345</a>.</cite></span></li><li id="cite_note-FujimuraTakayama2018-58"> <span id="mw-reference-text-cite_note-FujimuraTakayama2018-58" class="mw-reference-text"><cite id="CITEREFFujimuraTakayamaTakahashiInoue2018" class="citation journal cs1">Fujimura, Tetsuya; Takayama, Kenichi; Takahashi, Satoru; Inoue, Satoshi (2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061" class="external text external">"Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine"</a>. <i>Cancers</i>. <b>10</b> (2): 29. doi:<a href="javascript:if(confirm('https://doi.org/10.3390%2Fcancers10020029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3390%2Fcancers10020029'" tppabs="https://doi.org/10.3390%2Fcancers10020029" class="external text external">10.3390/cancers10020029</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2072-6694  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2072-6694'" tppabs="https://www.worldcat.org/issn/2072-6694" class="external text external">2072-6694</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061" class="external text external">5836061</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29360794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29360794'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29360794" class="external text external">29360794</a>.</cite></span></li><li id="cite_note-pmid28849318-59"> <span id="mw-reference-text-cite_note-pmid28849318-59" class="mw-reference-text"><cite id="CITEREFWangDongWangLi2017" class="citation journal cs1">Wang Q, Dong X, Wang Y, Li X (2017). "Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials". <i>Arch Womens Ment Health</i>. <b>21</b> (1): 31–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00737-017-0773-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00737-017-0773-2'" tppabs="https://doi.org/10.1007%2Fs00737-017-0773-2" class="external text external">10.1007/s00737-017-0773-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28849318  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28849318'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28849318" class="external text external">28849318</a>.</cite></span></li><li id="cite_note-pmid22549172-60"> <span id="mw-reference-text-cite_note-pmid22549172-60" class="mw-reference-text"><cite id="CITEREFCarneirode_Cassia_de_Maio_DardesHaidar2012" class="citation journal cs1">Carneiro AL, de Cassia de Maio Dardes R, Haidar MA (July 2012). "Estrogens plus raloxifene on endometrial safety and menopausal symptoms--semisystematic review". <i>Menopause</i>. <b>19</b> (7): 830–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2Fgme.0b013e31824a74ce  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2Fgme.0b013e31824a74ce'" tppabs="https://doi.org/10.1097%2Fgme.0b013e31824a74ce" class="external text external">10.1097/gme.0b013e31824a74ce</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22549172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22549172'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22549172" class="external text external">22549172</a>.</cite></span></li><li id="cite_note-pmid18622190-61"> <span id="mw-reference-text-cite_note-pmid18622190-61" class="mw-reference-text"><cite id="CITEREFNordtDiVasta2008" class="citation journal cs1">Nordt CA, DiVasta AD (2008). "Gynecomastia in adolescents". <i>Curr. Opin. Pediatr</i>. <b>20</b> (4): 375–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FMOP.0b013e328306a07c  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FMOP.0b013e328306a07c'" tppabs="https://doi.org/10.1097%2FMOP.0b013e328306a07c" class="external text external">10.1097/MOP.0b013e328306a07c</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18622190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18622190'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18622190" class="external text external">18622190</a>.</cite></span></li><li id="cite_note-pmid28260521-62"> <span id="mw-reference-text-cite_note-pmid28260521-62" class="mw-reference-text"><cite id="CITEREFLeungLeung2017" class="citation journal cs1">Leung KC, Leung AC (2017). "Gynecomastia in Infants, Children, and Adolescents". <i>Recent Pat Endocr Metab Immune Drug Discov</i>. <b>10</b> (2): 127–137. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F1872214811666170301124033  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F1872214811666170301124033'" tppabs="https://doi.org/10.2174%2F1872214811666170301124033" class="external text external">10.2174/1872214811666170301124033</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28260521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28260521'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28260521" class="external text external">28260521</a>.</cite></span></li><li id="cite_note-pmid15238910-63"> <span id="mw-reference-text-cite_note-pmid15238910-63" class="mw-reference-text"><cite id="CITEREFLawrenceFaughtVethamuthuLawson2004" class="citation journal cs1">Lawrence SE, Faught KA, Vethamuthu J, Lawson ML (July 2004). "Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia". <i>J. Pediatr</i>. <b>145</b> (1): 71–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpeds.2004.03.057  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpeds.2004.03.057'" tppabs="https://doi.org/10.1016%2Fj.jpeds.2004.03.057" class="external text external">10.1016/j.jpeds.2004.03.057</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15238910  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15238910'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15238910" class="external text external">15238910</a>.</cite></span></li><li id="cite_note-KanakisNordkap2019-64"> <span id="mw-reference-text-cite_note-KanakisNordkap2019-64" class="mw-reference-text"><cite id="CITEREFKanakisNordkapBangCalogero2019" class="citation journal cs1">Kanakis, G. A.; Nordkap, L.; Bang, A. K.; Calogero, A. E.; Bártfai, G.; Corona, G.; Forti, G.; Toppari, J.; Goulis, D. G.; Jørgensen, N. (2019). <a href="javascript:if(confirm('https://doi.org/10.1111/andr.12636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111/andr.12636'" tppabs="https://doi.org/10.1111/andr.12636" class="external text external">"EAA clinical practice guidelines—gynecomastia evaluation and management"</a>. <i>Andrology</i>. <b>7</b> (6): 778–793. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1111%2Fandr.12636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fandr.12636'" tppabs="https://doi.org/10.1111%2Fandr.12636" class="external text external">10.1111/andr.12636</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2047-2919  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2047-2919'" tppabs="https://www.worldcat.org/issn/2047-2919" class="external text external">2047-2919</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31099174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31099174'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31099174" class="external text external">31099174</a>.</cite></span></li><li id="cite_note-SugiyamaBarros2010-65"> <span id="mw-reference-text-cite_note-SugiyamaBarros2010-65" class="mw-reference-text"><cite id="CITEREFSugiyamaBarrosWarnerGustafsson2010" class="citation journal cs1">Sugiyama, Nobuhiro; Barros, Rodrigo P.A.; Warner, Margaret; Gustafsson, Jan-Åke (2010). "ERβ: recent understanding of estrogen signaling". <i>Trends in Endocrinology &amp; Metabolism</i>. <b>21</b> (9): 545–552. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tem.2010.05.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tem.2010.05.001'" tppabs="https://doi.org/10.1016%2Fj.tem.2010.05.001" class="external text external">10.1016/j.tem.2010.05.001</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1043-2760  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1043-2760'" tppabs="https://www.worldcat.org/issn/1043-2760" class="external text external">1043-2760</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20646931  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20646931'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20646931" class="external text external">20646931</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFBarrett-Connor_E2001" class="citation journal cs1">Barrett-Connor E (2001). "Raloxifene: risks and benefits". <i>Ann N Y Acad Sci</i>. <b>949</b> (1): 295–303. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2001NYASA.949..295B  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2001NYASA.949..295B'" tppabs="https://ui.adsabs.harvard.edu/abs/2001NYASA.949..295B" class="external text external">2001NYASA.949..295B</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1749-6632.2001.tb04036.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1749-6632.2001.tb04036.x'" tppabs="https://doi.org/10.1111%2Fj.1749-6632.2001.tb04036.x" class="external text external">10.1111/j.1749-6632.2001.tb04036.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11795366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11795366'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11795366" class="external text external">11795366</a>.</cite></li>
<li><cite id="CITEREFHeringa_M2003" class="citation journal cs1">Heringa M (2003). "Review on raloxifene: profile of a selective estrogen receptor modulator". <i>Int J Clin Pharmacol Ther</i>. <b>41</b> (8): 331–45. doi:<a href="javascript:if(confirm('https://doi.org/10.5414%2Fcpp41331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5414%2Fcpp41331'" tppabs="https://doi.org/10.5414%2Fcpp41331" class="external text external">10.5414/cpp41331</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12940590  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12940590'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12940590" class="external text external">12940590</a>.</cite></li>
<li><cite id="CITEREFSpornDowsettMershonBryant2004" class="citation journal cs1">Sporn MB, Dowsett SA, Mershon J, Bryant HU (2004). "Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action". <i>Clin Ther</i>. <b>26</b> (6): 830–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0149-2918%2804%2990127-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0149-2918%2804%2990127-0'" tppabs="https://doi.org/10.1016%2Fs0149-2918%2804%2990127-0" class="external text external">10.1016/s0149-2918(04)90127-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15262454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15262454'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15262454" class="external text external">15262454</a>.</cite></li>
<li><cite id="CITEREFVogel2009" class="citation journal cs1">Vogel VG (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785111'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785111" class="external text external">"The NSABP Study of Tamoxifen and Raloxifene (STAR) trial"</a>. <i>Expert Rev Anticancer Ther</i>. <b>9</b> (1): 51–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14737140.9.1.51  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14737140.9.1.51'" tppabs="https://doi.org/10.1586%2F14737140.9.1.51" class="external text external">10.1586/14737140.9.1.51</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785111'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785111" class="external text external">2785111</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19105706  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19105706'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19105706" class="external text external">19105706</a>.</cite></li>
<li><cite id="CITEREFWickerhamCostantinoVogelCronin2009" class="citation journal cs1">Wickerham DL, Costantino JP, Vogel VG, Cronin WM, Cecchini RS, Ford LG, Wolmark N (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110043'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110043" class="external text external">"The use of tamoxifen and raloxifene for the prevention of breast cancer"</a>. <i>Recent Results Cancer Res</i>. Recent Results in Cancer Research. <b>181</b>: 113–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-540-69297-3_12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-540-69297-3_12'" tppabs="https://doi.org/10.1007%2F978-3-540-69297-3_12" class="external text external">10.1007/978-3-540-69297-3_12</a>. ISBN<span>&nbsp;</span><bdi>978-3-540-69296-6</bdi>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110043'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110043" class="external text external">5110043</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19213563  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19213563'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19213563" class="external text external">19213563</a>.</cite></li>
<li><cite id="CITEREFVogel2011" class="citation journal cs1">Vogel VG (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846694  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846694'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846694" class="external text external">"Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women"</a>. <i>Breast Cancer: Targets and Therapy</i>. <b>3</b>: 127–37. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FBCTT.S11288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FBCTT.S11288'" tppabs="https://doi.org/10.2147%2FBCTT.S11288" class="external text external">10.2147/BCTT.S11288</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846694  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846694'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846694" class="external text external">3846694</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24367182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24367182'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24367182" class="external text external">24367182</a>.</cite></li>
<li><cite class="citation journal cs1">Yang ZD, Yu J, Zhang Q (2013). "Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials". <i>Maturitas</i>. <b>75</b> (4): 341–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2013.05.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2013.05.010'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2013.05.010" class="external text external">10.1016/j.maturitas.2013.05.010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23764354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23764354'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23764354" class="external text external">23764354</a>.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/raloxifene  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/raloxifene'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/raloxifene" class="external text external">"Raloxifene"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Estrogens_and_antiestrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogens_and_antiestrogens" style="font-size:114%;margin:0 4em">Estrogens and antiestrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Estrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li>Certain androgens/anabolic steroids (e.g., testosterone, testosterone esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone, nandrolone esters) (via estrogenic metabolites)</li>
<li>Certain progestins (e.g., <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a>, noretynodrel, <a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">etynodiol diacetate</a>, tibolone)</li>
<li>Clomestrone</li>
<li>Cloxestradiol acetate</li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Epiestriol</li>
<li>Epimestrol</li>
<li>Esterified estrogens</li>
<li>Estetrol<sup>†</sup></li>
<li>Estradiol</li>
<li>Estradiol esters (e.g., estradiol acetate, estradiol benzoate, estradiol cypionate, estradiol enanthate, estradiol undecylate, estradiol valerate, polyestradiol phosphate, estradiol ester mixtures (Climacteron))</li>
<li>Estramustine phosphate</li>
<li>Estriol</li>
<li>Estriol esters (e.g., estriol succinate, polyestriol phosphate)</li>
<li>Estrogenic substances</li>
<li>Estrone</li>
<li>Estrone esters
<ul><li>Estrone sulfate</li>
<li>Estropipate (piperazine estrone sulfate)</li></ul></li>
<li>Ethinylestradiol<sup>#</sup>
<ul><li>Ethinylestradiol sulfonate</li></ul></li>
<li>Hydroxyestrone diacetate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Nilestriol</li>
<li>Prasterone (dehydroepiandrosterone; DHEA)
<ul><li>Prasterone enanthate</li>
<li>Prasterone sulfate</li></ul></li>
<li>Promestriene</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Benzestrol</li>
<li>Bifluranol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol (stilbestrol)</a></li>
<li>Diethylstilbestrol esters/ethers
<ul><li>Dimestrol (diethylstilbestrol dimethyl ether)</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Mestilbol (diethylstilbestrol monomethyl ether)</li></ul></li>
<li>Doisynoestrol (fenocycline)</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol (promethestrol)
<ul><li>Methestrol dipropionate (promethestrol dipropionate)</li></ul></li>
<li>Paroxypropione</li>
<li>Quadrosilan</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiandrogens (e.g., <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr> (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <abbr>FSH</abbr>, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiestrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> antagonists<br>(incl. <abbr>SERMs</abbr>/<abbr>SERDs</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acolbifene<sup>†</sup></li>
<li>Anordrin</li>
<li>Bazedoxifene</li>
<li>Broparestrol</li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a><sup>#</sup></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li>Enclomifene<sup>†</sup></li>
<li>Epitiostanol</li>
<li>Lasofoxifene</li>
<li>Mepitiostane</li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a><sup>#</sup></li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li></ul>

<ul><li><i>Exclusively antagonistic:</i> <a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Aromatase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>First-generation:</i> <a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a></li></ul>

<ul><li><i>Second-generation:</i> Fadrozole</li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li></ul>

<ul><li><i>Third-generation:</i> <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Letrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Letrozole" title="Letrozole">Letrozole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens/anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>, testosterone esters, nandrolone esters, <a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">oxandrolone</a>, <a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">fluoxymesterone</a>)</li>
<li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>, <a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">goserelin</a>)</li>
<li><abbr>GnRH</abbr> antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>, elagolix)</li>
<li>Progestogens (e.g., chlormadinone acetate, cyproterone acetate, gestonorone caproate, hydroxyprogesterone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Mixed mechanism of action:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li></ul>

<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Estrogen receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of estrogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Estrogen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogen_receptor_modulators" style="font-size:114%;margin:0 4em">Estrogen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol</li>
<li>3α-Androstanediol</li>
<li><span class="new">3α,5α-Dihydrolevonorgestrel</span></li>
<li><span class="new">3β,5α-Dihydrolevonorgestrel</span></li>
<li>3α-Hydroxytibolone</li>
<li>3β-Hydroxytibolone</li>
<li>3β-Androstanediol</li>
<li><a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">4-Androstenedione</a></li>
<li>4-Fluoroestradiol</li>
<li>4-Hydroxyestradiol</li>
<li>4-Hydroxyestrone</li>
<li>4-Methoxyestradiol</li>
<li>4-Methoxyestrone</li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">5-Androstenediol</a></li>
<li>7-Oxo-DHEA</li>
<li>7α-Hydroxy-DHEA</li>
<li>7α-Methylestradiol</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>8,9-Dehydroestradiol</li>
<li>8,9-Dehydroestrone</li>
<li>8β-VE2</li>
<li>10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)</li>
<li>11β-Chloromethylestradiol</li>
<li>11β-Methoxyestradiol</li>
<li>15α-Hydroxyestradiol</li>
<li>16-Ketoestradiol</li>
<li>16-Ketoestrone</li>
<li>16α-Fluoroestradiol</li>
<li>16α-Hydroxy-DHEA</li>
<li>16α-Hydroxyestrone</li>
<li>16α-Iodoestradiol</li>
<li>16α-LE2</li>
<li>16β-Hydroxyestrone</li>
<li>16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)</li>
<li>17α-Estradiol (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">alfatradiol</a>)</li>
<li>17α-Dihydroequilenin</li>
<li>17α-Dihydroequilin</li>
<li>17α-Epiestriol (16α-hydroxy-17α-estradiol)</li>
<li>17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>17β-Dihydroequilenin</li>
<li>17β-Dihydroequilin</li>
<li>17β-Methyl-17α-dihydroequilenin</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Alestramustine</li>
<li>Almestrone</li>
<li>Anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> and esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone (methandrostenolone), <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, many others; via estrogenic metabolites)</li>
<li>Atrimustine</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Butolame</li>
<li>Clomestrone</li>
<li>Cloxestradiol
<ul><li>Cloxestradiol acetate</li></ul></li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Cyclodiol</li>
<li>Cyclotriol</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA-S</a></li>
<li><i>ent</i>-Estradiol</li>
<li>Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)</li>
<li>Epimestrol</li>
<li><a href="Equilenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilenin" title="Equilenin">Equilenin</a></li>
<li><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></li>
<li>ERA-63 (ORG-37663)</li>
<li>Esterified estrogens</li>
<li>Estetrol</li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a>
<ul><li>Estradiol esters</li>
<li>Lipoidal estradiol</li>
<li>Polyestradiol phosphate</li></ul></li>
<li><a href="Estramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Estramustine" title="Estramustine">Estramustine</a></li>
<li>Estramustine phosphate</li>
<li>Estrapronicate</li>
<li>Estrazinol</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a>
<ul><li>Estriol esters</li>
<li>Polyestriol phosphate</li></ul></li>
<li>Estrofurate</li>
<li>Estrogenic substances</li>
<li>Estromustine</li>
<li><a href="Estrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrone" title="Estrone">Estrone</a>
<ul><li>Estrone esters</li>
<li>Estrone methyl ether</li>
<li>Estropipate</li></ul></li>
<li>Etamestrol (eptamestrol)</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li>Ethinylestradiol
<ul><li>Ethinylestradiol 3-benzoate</li>
<li>Ethinylestradiol sulfonate</li></ul></li>
<li>Ethinylestriol</li>
<li>Ethylestradiol</li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Hexolame</li>
<li>Hippulin</li>
<li>Hydroxyestrone diacetate</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Mytatrienediol</li>
<li>Nilestriol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Noretynodrel</li>
<li>Orestrate</li>
<li>Pentolame</li>
<li>Prodiame</li>
<li>Prolame</li>
<li>Promestriene</li>
<li>RU-16117</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li>
<li>Tibolone</li></ul>

<ul><li><i>Nonsteroidal:</i> (R,R)-THC</li>
<li>(S,S)-THC</li>
<li>2,8-DHHHC</li>
<li><span class="new">β-LGND1</span></li>
<li>β-LGND2 (GTx-878)</li>
<li><span class="new">AC-186</span></li>
<li>Allenestrol</li>
<li>Allenolic acid</li>
<li>Benzestrol</li>
<li>Bifluranol</li>
<li>Bisdehydrodoisynolic acid</li>
<li>Butestrol</li>
<li>Carbestrol</li>
<li>D-15414</li>
<li>DCW234</li>
<li>Diarylpropionitrile</li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a>
<ul><li>Diethylstilbestrol esters</li></ul></li>
<li>Dimestrol (dianisylhexene)</li>
<li>Dimethylstilbestrol</li>
<li>Doisynoestrol (fenocycline)</li>
<li>Doisynolic acid</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>ERB-196 (WAY-202196)</li>
<li>Erteberel (SERBA-1, LY-500307)</li>
<li>Estrobin (DBE)</li>
<li>Fenestrel</li>
<li>FERb 033</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Furostilbestrol (diethylstilbestrol difuroate)</li>
<li>GTx-758</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li>ICI-85966 (Stilbostat)</li>
<li>M2613</li>
<li><i>meso</i>-Butestrol</li>
<li><i>meso</i>-Hexestrol</li>
<li>Mestilbol</li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol</li>
<li>Methestrol dipropionate</li>
<li>Paroxypropione</li>
<li>Pentafluranol</li>
<li>Phenestrol</li>
<li>Prinaberel (ERB-041, WAY-202041)</li>
<li>Propylpyrazoletriol</li>
<li>Quadrosilan</li>
<li><span class="new">SC-3296</span></li>
<li>SC-4289</li>
<li>SERBA-2</li>
<li>SKF-82,958</li>
<li>Terfluranol</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li>Triphenyliodoethylene</li>
<li>Triphenylmethylethylene (triphenylpropene)</li>
<li>WAY-166818</li>
<li><span class="new">WAY-169916</span></li>
<li>WAY-200070</li>
<li>WAY-204688 (SIM-688)</li>
<li>WAY-214156</li></ul>

<ul><li><i>Unknown/unsorted:</i> ERB-26</li>
<li>ERA-45</li>
<li>ERB-79</li>
<li>ZK-283197</li></ul>

<ul><li><i>Xenoestrogens:</i> <a href="Anise.htm" tppabs="https://ptable.com/wiki/compounds/A/Anise" title="Anise">Anise</a>-related (e.g., <a href="Anethole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anethole" title="Anethole">anethole</a>, anol, dianethole, dianol, photoanethole)</li>
<li>Chalconoids (e.g., <a href="Isoliquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoliquiritigenin" title="Isoliquiritigenin">isoliquiritigenin</a>, <a href="Phloretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phloretin" title="Phloretin">phloretin</a>, <a href="Phlorizin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phlorizin" title="Phlorizin">phlorizin (phloridzin)</a>, wedelolactone)</li>
<li>Coumestans (e.g., <a href="Coumestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumestrol" title="Coumestrol">coumestrol</a>, psoralidin)</li>
<li><a href="Flavonoid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavonoid" title="Flavonoid">Flavonoids</a> (incl. 7,8-DHF, 8-prenylnaringenin, <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">apigenin</a>, <a href="Baicalein.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalein" title="Baicalein">baicalein</a>, <a href="Baicalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalin" title="Baicalin">baicalin</a>, <a href="Biochanin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Biochanin_A" title="Biochanin A">biochanin A</a>, <a href="Calycosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Calycosin" title="Calycosin">calycosin</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">catechin</a>, <a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">daidzein</a>, daidzin, ECG, <a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">EGCG</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">epicatechin</a>, <a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">equol</a>, <a href="Formononetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Formononetin" title="Formononetin">formononetin</a>, glabrene, glabridin, <a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">genistein</a>, <a href="Genistin.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistin" title="Genistin">genistin</a>, <a href="Glycitein.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycitein" title="Glycitein">glycitein</a>, <a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">kaempferol</a>, <a href="Liquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Liquiritigenin" title="Liquiritigenin">liquiritigenin</a>, mirificin, <a href="Myricetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Myricetin" title="Myricetin">myricetin</a>, <a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">naringenin</a>, <span class="new">penduletin</span>, pinocembrin, <a href="Prunetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prunetin" title="Prunetin">prunetin</a>, puerarin, <a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">quercetin</a>, tectoridin, tectorigenin)</li>
<li>Lavender oil</li>
<li>Lignans (e.g., enterodiol, enterolactone, nyasol (<i>cis</i>-hinokiresinol))</li>
<li>Metalloestrogens (e.g., <a href="Cadmium.htm" tppabs="https://ptable.com/wiki/compounds/A/Cadmium" title="Cadmium">cadmium</a>)</li>
<li>Pesticides (e.g., alternariol, <a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">dieldrin</a>, <a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">endosulfan</a>, <a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">fenarimol</a>, HPTE, <a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">methiocarb</a>, <a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">methoxychlor</a>, <a href="Triclocarban.htm" tppabs="https://ptable.com/wiki/compounds/A/Triclocarban" title="Triclocarban">triclocarban</a>, triclosan)</li>
<li>Phytosteroids (e.g., <a href="Digitoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digitoxin" title="Digitoxin">digitoxin</a> (digitalis), <a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">diosgenin</a>, guggulsterone)</li>
<li><a href="Phytosterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Phytosterol" title="Phytosterol">Phytosterols</a> (e.g., β-sitosterol, <a href="Campesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Campesterol" title="Campesterol">campesterol</a>, <a href="Stigmasterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stigmasterol" title="Stigmasterol">stigmasterol</a>)</li>
<li>Resorcylic acid lactones (e.g., zearalanone, α-zearalenol, β-zearalenol, <a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">zearalenone</a>, <a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">zeranol (α-zearalanol)</a>, taleranol (teranol, β-zearalanol))</li>
<li>Steroid-like (e.g., deoxymiroestrol, miroestrol)</li>
<li>Stilbenoids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">resveratrol</a>, <a href="Rhaponticin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rhaponticin" title="Rhaponticin">rhaponticin</a>)</li>
<li>Synthetic xenoestrogens (e.g., alkylphenols, <a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">bisphenols</a> (e.g., <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">BPA</a>, BPF, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">BPS</a>), DDT, parabens, <a href="Polybrominated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polybrominated_biphenyl" title="Polybrominated biphenyl">PBBs</a>, PHBA, phthalates, <a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a>)</li>
<li>Others (e.g., agnuside, <span class="new">rotundifuran</span>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SERMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">2-Phenylbenzofuran</span></li>
<li><span class="new">2-Phenylbenzothiophene</span></li>
<li>4'-Hydroxynorendoxifen</li>
<li>27-Hydroxycholesterol</li>
<li>Acefluranol</li>
<li>Acolbifene</li>
<li>Afimoxifene</li>
<li>Anordiol</li>
<li>Anordrin</li>
<li>Arzoxifene</li>
<li>Bazedoxifene</li>
<li>Brilanestrant</li>
<li>Broparestrol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></li>
<li>Clomifenoxide</li>
<li><span class="new">CN-55945-27</span></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li><span class="new">D-15413</span></li>
<li>Desmethylchlorotrianisene</li>
<li>Droloxifene</li>
<li>Elacestrant</li>
<li>Enclomifene</li>
<li>Endoxifen</li>
<li>Etacstil (GW-5638, DPC-974)</li>
<li>Ethamoxytriphetol (MER-25)</li>
<li>Femarelle</li>
<li>Fispemifene</li>
<li><span class="new">GW-7604</span></li>
<li><span class="new">ICI-55548</span></li>
<li><a href="Idoxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxifene" title="Idoxifene">Idoxifene</a></li>
<li>Lasofoxifene</li>
<li>Levormeloxifene</li>
<li>LN-1643</li>
<li>LN-2299</li>
<li><span class="new">LY-117018</span></li>
<li>Menerba</li>
<li>Miproxifene</li>
<li>Miproxifene phosphate</li>
<li><span class="new">MRL-37</span></li>
<li>Nafoxidine</li>
<li>Nitromifene</li>
<li>NNC 45-0095</li>
<li><span class="new">NNC 45-0320</span></li>
<li><span class="new">NNC 45-0781</span></li>
<li><span class="new">NNC 45-1506</span></li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li>Panomifene</li>
<li>Pipendoxifene</li>
<li><span class="new">Promensil</span></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li>Rimostil (P-081)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li><span class="new">SS1010</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>TAS-108 (SR-16234)</li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li>
<li>Trioxifene</li>
<li><span class="new">TZE-5323</span></li>
<li><span class="new">U-11555A</span></li>
<li><span class="new">U-11634</span></li>
<li><span class="new">Y-134</span></li>
<li>Zindoxifene</li>
<li>Zuclomifene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(R,R)-THC</li>
<li>7β-Hydroxy-DHEA</li>
<li><span class="new">Chloroindazole</span></li>
<li>Cytestrol acetate</li>
<li><span class="new">EM-800 (SCH-57050)</span></li>
<li>Epitiostanol</li>
<li><span class="new">ERA-90</span></li>
<li><span class="new">ERB-88</span></li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><a href="Glyceollin.htm" tppabs="https://ptable.com/wiki/compounds/A/Glyceollin" title="Glyceollin">Glyceollins</a> (I, <span class="new">II</span>, III, <span class="new">IV</span>)</li>
<li>ICI-164384</li>
<li><span class="new">MDL-101906</span></li>
<li>Mepitiostane</li>
<li>Methylepitiostanol</li>
<li>Methylpiperidinopyrazole</li>
<li>MIBE</li>
<li><span class="new">Oxabicycloheptene sulfonate</span></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>PHTPP</li>
<li>Prochloraz</li>
<li><span class="new">RU-39411</span></li>
<li><span class="new">RU-58668</span></li>
<li><span class="new">SS1020</span></li>
<li>TAS-108 (SR-16234)</li>
<li>ZB716</li>
<li><span class="new">ZK-164015</span></li>
<li><span class="new">ZK-191703</span></li></ul>

<ul><li><i>Coregulator-binding modulators:</i> ERX-11</li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>7β-Hydroxyepiandrosterone</li>
<li>Afimoxifene (4-hydroxytamoxifen)</li>
<li><a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">Aldosterone</a></li>
<li><a href="Atrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atrazine" title="Atrazine">Atrazine</a></li>
<li><a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">Bisphenol A</a></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li>DDT (p,p'-DDT, <span class="new">o',p'-DDE</span>)</li>
<li>Diarylpropionitrile</li>
<li><a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">Equol</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li>Ethinylestradiol</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><span class="new">G-1</span></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><span class="new">GPER-L1</span></li>
<li><span class="new">GPER-L2</span></li>
<li>Hydroxytyrosol</li>
<li><a href="Kepone.htm" tppabs="https://ptable.com/wiki/compounds/A/Kepone" title="Kepone">Kepone</a></li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li><a href="Nicotinamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinamide" title="Nicotinamide">Nicotinamide</a></li>
<li><a href="Nonylphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nonylphenol" title="Nonylphenol">Nonylphenol</a></li>
<li><a href="Oleuropein.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleuropein" title="Oleuropein">Oleuropein</a></li>
<li><a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a> (<span class="new">2,2',5'-PCB-4-OH</span>)</li>
<li>Propylpyrazoletriol</li>
<li><a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">Quercetin</a></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">Resveratrol</a></li>
<li><span class="new">STX</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Tectoridin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CCL18</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a></li>
<li><span class="new">G-15</span></li>
<li><span class="new">G-36</span></li>
<li>MIBE</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Unknown</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li>
<li><a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">Zearalenone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of estrogens</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Other_sex_hormones_and_modulators_of_the_genital_system_(G03X)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Other_sex_hormones_and_modulators_of_the_genital_system_(G03X)" style="font-size:114%;margin:0 4em">Other sex hormones and modulators of the genital system (G03X)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antigonadotropins (G03XA)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li>Anti-Pmsg</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antiprogestogens (G03XB)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>Ulipristal</li>
<li>Aglepristone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Selective estrogen<br>receptor modulators (G03XC)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li>Bazedoxifene</li>
<li>Lasofoxifene</li>
<li>Ormeloxifene</li>
<li>Ospemifene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others (G03XX)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Prasterone</li></ul>
</div></td></tr></tbody></table></div>













<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>